Drug Cos. Float Deals Worth $50B To End Opioid Cases
By Jeff Overley and Emily Field · October 16, 2019, 7:30 PM EDT
Major drug manufacturers and distributors — including Johnson & Johnson and McKesson — are proposing deals that could be worth a combined $50 billion to resolve large portions of nationwide litigation...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login